Elite Pharmaceuticals Inc (ELTP) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2026, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Elite Pharmaceuticals Inc   (ELTP)
 

Elite Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Elite Pharmaceuticals Inc 's inventory turnover ratio, the ratio that measures Elite Pharmaceuticals Inc 's ability to manage its supply chain, sequentially decreased to 3.48 in the second quarter 2026, but it does not raise any concerns as Elite Pharmaceuticals Inc continue to execute well, and the inventory turnover ratio remains above the average. Elite Pharmaceuticals Inc 's average inventory processing period in the Sep 30 2026 quarter, has increased to 105 days, from 103 days, in the Jun 30 2026 quarter.

Within Healthcare sector 114 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1128, from total ranking in the first quarter 2026 at 1154.

ELTP Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Elite Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ELTP Inventory Turnover Ratio (Sep 30 2026)
II. Quarter		 (Jun 30 2026)
I. Quarter		 (Mar 31 2026)
IV. Quarter		 (Dec 31 2025)
III. Quarter		 (Sep 30 2025)
II. Quarter
Y / Y Inventory Growth 23.97 % 25.02 % 30.91 % 24.51 % 28.24 %
Y / Y Cost of Sales Growth 9.52 % 57.06 % 33.17 % 125 % 120 %
Inventory Turnover Ratio (TTM) 3.48 3.55 3.43 3.4 3.08
ELTP's Total Ranking # 1128 # 1154 # 333 # 1019 #
Average inventory processing period 105 103 106 107 118
Seq. Inventory Growth -6.95 % 13.83 % -15.3 % 38.17 % -6.16 %
Seq. Cost of Sales Growth 27.84 % -5.65 % 10.98 % -18.18 % 83.33 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 24
Healthcare Sector # 115
Overall Market # 1128

Inventory Turnover Ratio Statistics
High Average Low
3.95 2.1 0.53
(Jun 30 2026)   (Dec 31 2017)



ELTP Company Profile >> Back to ELTP Efficiency Comparisons >> Compare ELTP Inventory Turnover Ratio to its Competitors

Financial Statements
Elite Pharmaceuticals Inc 's Inventories $ 23 Millions Visit ELTP's Balance sheet
Elite Pharmaceuticals Inc 's Cost of Revenues TTM $ 81 Millions Visit ELTP's Income Statement
What are ELTP's Sales? Visit ELTP's Sales by Segment

Other Inventory Turnover Ratios
Elite Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ELTP's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ELTP's Competitors
Inventory Turnover Ratio for ELTP's Suppliers
Inventory Turnover Ratio for ELTP's Customers

You may also want to know
ELTP's Sales Growth Rates ELTP's Pe Price to earnings ratio ELTP's Receivables Turnover Ratio ELTP's Stock Quote
ELTP's Net Income Growth Rates ELTP's Ps Price to Sales ratio ELTP's Sales per Employee ELTP's Asset Turnover Ratio
ELTP's Net Margin ELTP's Pb Price to Book ratio ELTP's Financial Strength Ratios ELTP's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Lantheus Holdings Inc   9.76 $ 604.826  Millions$ 62  Millions
Vanda Pharmaceuticals Inc   8.70 $ 14.704  Millions$ 2  Millions
Phathom Pharmaceuticals Inc   7.76 $ 53.106  Millions$ 7  Millions
Novavax inc   7.03 $ 90.533  Millions$ 13  Millions
Carlisle Companies Incorporated  6.99 $ 3,406.400  Millions$ 488  Millions
Cardiff Lexington Corporation  6.98 $ 3.768  Millions$ 1  Millions
Carlsmed Inc   6.91 $ 15.844  Millions$ 2  Millions
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Edap Tms Sa  6.14 $ 60.833  Millions$ 10  Millions
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Myomo Inc   4.58 $ 14.802  Millions$ 3  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Autolus Therapeutics Plc  4.34 $ 88.293  Millions$ 20  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
Electromed Inc   4.18 $ 14.878  Millions$ 4  Millions
Intelligent Bio Solutions Inc   4.14 $ 2.206  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Sonoma Pharmaceuticals Inc   3.90 $ 14.275  Millions$ 4  Millions
Koru Medical Systems Inc   3.88 $ 16.831  Millions$ 4  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions

Date modified: 2026-11-13T11:56:10+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.